Transcription factors of the STAT family are critical in the cytokine-mediated functional differentiation of CD4 + helper T cells. Signaling inhibitors of the SOCS family negatively regulate the activation of STAT proteins; however, their roles in the differentiation and function of helper T cells are not well understood. Here we found that the SOCS protein CIS, which was substantially induced by interleukin 4 (IL-4), negatively regulated the activation of STAT3, STAT5 and STAT6 in T cells. CIS-deficient mice spontaneously developed airway inflammation, and CIS deficiency in T cells led to greater susceptibility to experimental allergic asthma. CIS-deficient T cells showed enhanced differentiation into the T H 2 and T H 9 subsets of helper T cells. STAT5 and STAT6 regulated IL-9 expression by directly binding to the Il9 promoter. Our data thus demonstrate a critical role for CIS in controlling the proallergic generation of helper T cells. 
A r t i c l e s CD4 + helper T cells are the central organizers of adaptive immunity and various immunological diseases. After recognizing antigens, naive precursors of CD4 + T cells undergo clonal expansion and functional differentiation into cytokine-secreting effector cells. The effector differentiation of cells into the T H 1, T H 2 and T H 17 and T H 9 subsets of helper T cells is determined by the cytokine environment 1,2 . T H 1 differentiation is promoted by interleukin 12 (IL-12), which signals through the intracellular signaling molecule STAT4. The interferon-γ (IFN-γ)-STAT1 pathway in turn sustains T H 1 development, which leads to induction of expression of the transcription factor T-bet. During T H 2 polarization, IL-4 serves an essential role by activating STAT6, and phosphorylated STAT6 in turn induces expression of the transcription factor GATA-3 (ref. 3) . In addition to IL-4, IL-2 regulates T H 2 differentiation by STAT5-mediated induction of the α-chain of the receptor for IL-4 (IL-4Rα), the main STAT6-activating component of the IL-4 and IL-13 receptors [4] [5] [6] . T H 17 differentiation is mediated by a combination of signaling via IL-6 and transforming growth factor-β (TGF-β) 7 . IL-6, as well as IL-21 and IL-23, supports T H 17 development via STAT3 (ref. 7) , whereas IL-2-STAT5 signaling negatively regulates T H 17 differentiation 8 . IL-9-expressing T H 9 cells also require TGF-β, in addition to IL-4, for their generation [9] [10] [11] ; the mechanism for this remains unclear.
Thus, cytokine-mediated activation of STAT (signal transducer and activator of transcription) proteins has a pivotal role in the differentiation of helper T cells. Moreover, overactivation of STAT proteins may lead to excessive immune responses and tissue damage. Thus, signaling from STAT proteins is controlled by several negative regulatory mechanisms [12] [13] [14] . Among those, members of the SOCS (suppressor of cytokine signaling) family, induced by cytokine stimulation, inhibit STAT signaling [12] [13] [14] . For example, genetic deletion of SOCS1 in mice results in greater responsiveness to IFN-γ and causes a fatal inflammatory disease 15 . The eight members of the SOCS family (CIS ('cytokine-induced SH-2 protein'; also called CIS1, SOCS or CISH) 16 and SOCS1-SOCS7) share a common structure, with a central Src-homology 2 (SH2) domain, a carboxyl-terminal SOCS box and a divergent amino-terminal domain. The SOCS box interacts with ubiquitination enzymes, such as elongin B, elongin C, cullin-5 and RING box 2, and an E2 ubiquitin transferase. The central SH2 domain determines the interaction with target proteins, such as kinases of the Jak family, which brings them close to the ubiquitinating scaffold associated with the SOCS box. SOCS-mediated ubiquitination of the target proteins leads to rapid degradation via the proteasome and inhibition of cytokine signaling.
As negative regulators of STAT proteins, some members of the SOCS family are involved in the differentiation of helper T cells. SOCS1 negatively regulates T H 1 differentiation through inhibition of the IFN-γ-STAT1 and IL-12-STAT4 pathways [17] [18] [19] [20] . SOCS3 is 'preferentially' expressed in T H 2 cells 21 , and forced expression of SOCS3 in T cells promotes a T H 2 phenotype by blocking STAT4 signaling [22] [23] [24] . However, conditional removal of SOCS3 in T cells seems A r t i c l e s to suppress both T H 1 responses and T H 2 responses, an unexpectedly broad effect that may indirectly result from greater secretion of the immunosuppressive cytokines TGF-β and IL-10 (ref. 25) . In addition, SOCS3 blocks STAT3 signaling and inhibits T H 17 polarization 26, 27 . SOCS5 is 'preferentially' expressed in T H 1 cells. Although expression of SOCS5 negatively regulates IL-4-dependent activation of STAT6 and T H 2 differentiation during T H 1 differentiation 28 , the absence of SOCS5 from CD4 + T cells does not seem to alter normal T H 1 or T H 2 differentiation 29 . Regulatory T cells (T reg cells) have high expression of SOCS2, and it may be involved in their differentiation and/or function [12] [13] [14] . Except for SOCS1, SOCS3 and SOCS5, the function of the SOCS family in the effector differentiation of helper T cells has not been established.
CIS was first shown to inhibit signaling from the receptors for erythropoietin and growth hormone 16, 30, 31 . In CD4 + T cells, CIS inhibits STAT5 signaling 32, 33 , which suggests that it may be involved in the differentiation of helper T cells. In this study, we found that CIS, strongly induced by IL-4 in T cells, inhibited the phosphorylation of STAT3, STAT5 and STAT6. The absence of CIS in T cells led to more T H 2 and T H 9 differentiation and exacerbated airway allergic disease.
RESULTS

CIS expression in CD4 + T cells
T cell differentiation is initiated by signals from the T cell antigen receptor, costimulatory molecules and cytokine receptors. To characterize the role of CIS in T cell differentiation, we first assessed CIS expression during early activation of T cells. We sorted CD4 + CD25 − CD44 lo CD62L hi naive T cells from C67BL/6 mice by flow cytometry and activated the cells for various times with platebound antibody to CD3 (anti-CD3) and anti-CD28, then analyzed the expression of mRNA encoding CIS (Cish; called 'Cis' here), IL-2 (Il2) and IL-2Rα (Il2ra; called 'Cd25' here) by quantitative RT-PCR. We detected upregulation of Cis mRNA expression at 0.5 h, which reached a peak at 2 h, followed by downregulation at 8 h and a second peak at 48 h (Fig. 1a) . Il2 and Cd25 shared a similar pattern of expression; both had low expression in the first 8 h, and their expression peaked at 48 h (Fig. 1a) . These results suggested that in the early phase, Cis expression was independent of endogenous IL-2 production and expression of the high-affinity IL-2 receptor CD25 (IL-2Rα).
Next we assessed expression of Cis mRNA in response to a variety of cytokines that are important in T cell differentiation. After 3 h of activation with plate-bound anti-CD3 and anti-CD28, the addition of IL-6 and IL-10 weakly upregulated Cis mRNA expression, whereas IL-4 substantially upregulated Cis mRNA expression (Fig. 1b) . Consistent with that, blockade of IL-4 or IL-6 with neutralizing antibodies attenuated Cis mRNA expression (Fig. 1b) , and deficiency in the gene encoding IL-4Rα (Il4ra) abrogated IL-4-induced Cis mRNA expression (Supplementary Fig. 1a) . However, in STAT6-deficient cells, IL-4-dependent Cis mRNA expression was only slightly lower ( Supplementary Fig. 1b) , which suggested that other factors in addition to STAT6 were required for IL-4-induced Cis mRNA expression. Consistent with that, STAT6 bound to the Cis promoter (Supplementary Fig. 1c) , suggestive of direct regulation. Unexpectedly, at this early phase (3 h) of T cell differentiation, the addition of IL-2, a cytokine known to activate STAT5 (refs. 16,33) , did not induce Cis expression much (Fig. 1b) . Furthermore, we explored the expression of Cis mRNA in various helper T cell subsets and found high expression in T H 1 cells, T H 2 cells, inducible T reg cells (iT reg cells) and natural T reg cells (nT reg cells) and moderate expression in T H 9 cells (Fig. 1c) . Cis mRNA expression in T H 17 cells was similar to that in naive cells (Fig. 1c) . Together these data suggested possible involvement of CIS in the regulation of cytokine signaling during helper T cell differentiation.
CIS antagonizes STAT activation
To further understand the role of CIS in the differentiation and function of T cells, we generated mice with conditional deletion of Cis. We introduced two loxP sites into the Cis locus that flanked a region spanning exon 2 to the coding region of exon 3 ( Supplementary Fig. 2a ). We generated a Cis-deficient allele by breeding mice with that loxP-flanked Cis allele (Cis +/fl ) with mice that express Cre recombinase from the cytomegalovirus promoter (Supplementary Fig. 2b ). We backcrossed Cis +/− or Cis +/fl mice to C57BL/6 mice for seven to eight generations and then interbred the resulting mice to generate Cis −/− or Cis fl/fl mice. In Cis −/− mice, Cis mRNA was not detectable in bone marrow or T reg cells by RT-PCR (Supplementary Fig. 2c ), and CIS protein was completely absent from CD4 + T cells by immunoblot analysis ( Supplementary  Fig. 2d) , which indicated that a null mutation was generated and that CIS was not required for normal mouse development. The lymphoid populations in the thymus, spleen and lymph nodes of Cis −/− mice seemed grossly normal, although they had slightly more cells 
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A r t i c l e s than did their wild-type counterparts ( Supplementary Fig. 3 and data not shown). Also, the development of CD4 + CD25 + Foxp3 + nT reg cells in the thymus and spleen from Cis −/− mice seemed normal ( Supplementary Fig. 3b,c) .
When activated with plate-bound anti-CD3 and anti-CD28 in the presence or absence of exogenous IL-2, CIS-deficient CD4 + T cells had enhanced proliferation, but endogenous IL-2 secretion was not altered (Supplementary Fig. 4) . Moreover, Cis −/− nT reg cells had suppressive activity similar to or marginally less than that of their wild-type counterparts (Supplementary Fig. 5a ). In addition, Cis deficiency did not alter the expression of T reg cell-specific genes, such as Foxp3, Tg fb1, Il10, Il35 and Ctla4, as assessed in nT reg cells expressing the transcription factor Foxp3 linked to green fluorescent protein (GFP), sorted by flow cytometry (Supplementary Fig. 5b ).
As CIS is reported to inhibit STAT activation, we assessed the phosphorylation of STAT proteins in T cells. We activated wild-type and Cis −/− CD4 + T cells for various times with plate-bound anti-CD3 and anti-CD28 in the presence of recombinant human IL-2, then assessed phosphorylated and total STAT proteins by immunoblot. Cis −/− CD4 + T cells had more phosphorylated STAT3, STAT5 and STAT6 than did wild-type CD4 + T cells at various times, whereas the abundance of phosphorylated STAT1 remained the same in cells of each genotype (Fig. 1d) . Of note, wild-type cells had less phosphorylated STAT5 at 3 h (Fig. 1d) , which inversely correlated with CIS expression at 2-4 h (Fig. 1a and Supplementary Fig. 2d ). To further understand the original signals that activate STAT3, STAT5 and STAT6, we first assessed the effect of IL-2. In the absence of exogenous IL-2 (endogenous IL-2 was expressed only 8 h after activation; Fig. 1a ), phosphorylated STAT3 and STAT6 retained their enhanced activation in CIS-deficient cells, whereas the increase in phosphorylated STAT5 was greatly delayed and diminished, and we found no difference between wild-type and CIS-deficient cells (Supplementary Fig. 6a ), which suggested that phosphorylated STAT5 was triggered by IL-2. Moreover, after the addition of IL-4-neutralizing antibody, phosphorylated STAT6 signals were no longer detectable ( Supplementary  Fig. 6b ), which suggested that the activation of STAT6 required IL-4 in both wild-type cells and CIS-deficient cells. However, neutralization of IL-6 and/or IL-21 or IL-4 did not affect the activation of STAT3 ( Supplementary Fig. 6c,d ). In summary, these results indicated involvement of CIS in control of the IL-2-STAT5, IL-4-STAT6 and STAT3 pathways in CD4 + T cells. Fig. 7a ). The frequency of Foxp3 + cell was also similar for the two strains ( Fig. 2a and Supplementary Fig. 7a ). These data suggested that CIS may negatively regulate the proallergic differentiation of T cells in vivo.
We prepared lung, heart, liver, kidney and intestinal tissue sections from 10-month-old wild-type and Cis −/− mice and stained the sections with hematoxylin and eosin. We observed no difference between the genotypes for any tissues tested except that in contrast to wild-type lungs, Cis −/− lungs had parenchymal consolidation, narrowed airways and alveoli, hyperplasia of airway smooth muscle cells and goblet cell metaplasia (incidence, 80%; Fig. 2c ). Those histological features were more pronounced in all lungs from 18-month-old Cis −/− mice and included more severe airway obstruction due to mucus impaction and scattered infiltration of mononuclear cells (Fig. 2d) . By staining with Masson's trichrome and Periodic acid-Schiff, we found more collagen deposition in the peribronchovascular spaces (Fig. 2e) and more mucin staining (goblet-cell metaplasia) in the airway epithelium (Fig. 2f) in Cis −/− lungs than in wild-type lungs. Moreover, we observed significantly more infiltration of eosinophils in Cis −/− lungs than in wild-type lungs (P ≤ 0.05; Supplementary Fig. 7b ). Together these results indicated that CIS deficiency resulted in a spontaneous lung disorder that resembled allergic asthma; it was associated with a greater abundance of IL-4-and IL-9-secreting CD4 + T cells, which suggested that T H 2 and T H 9 cells may be involved in the disease process in these mice.
T cell-intrinsic role of CIS Because Cis −/− mice had spontaneous allergic responses, we induced allergic asthma in CIS-sufficient (Cis −/− ) mice and their CIS-sufficient counterparts (Cis fl/fl mice (Fig. 3) or wildtype littermates (Supplementary Fig. 8 ), as a control) by a standard protocol 34 . Cis −/− mice had significantly more total cells, eosinophils 
and lymphocytes in lung infiltrates than did CIS-sufficient mice ( Fig. 3a and Supplementary Fig. 8a ). There were more IL-4 + or IL-5 + CD4 + cells in lung infiltrates from Cis −/− mice than in those from CISsufficient mice ( Fig. 3b and Supplementary Fig. 8b ). Moreover, after ex vivo restimulation with various doses of ovalbumin, lung-associated lymph node cells and splenocytes from Cis −/− mice produced significantly more IL-4, IL-5 and IL-13 than did similarly restimulated cells from CIS-sufficient mice ( Fig. 3c and Supplementary Fig. 8c) . Consistent with that, total lung tissue from Cis −/− mice had higher expression of Il4, Il5, Il13 and Il9 mRNA than did that from CISsufficient mice ( Fig. 3d and Supplementary Fig. 8d ). These results suggest that the enhanced T H 2 and T H 9 responses in CIS-deficient mice were independent of the polymorphisms in the genome of the 129 mouse strain that surrounds the Cis locus because the Cis fl/fl mice had same Cis allele (that originated from the 129 strain) that the Cis −/− mice had. Next we assessed the T cell-intrinsic role of CIS in allergic lung responses. We induced asthma in Cis fl/fl CD4-Cre mice (the offspring of Cis fl/fl mice and mice that express Cre from the Cd4 promoter), Cis fl/fl Foxp3-Cre mice (the offspring of Cis fl/fl mice and mice that express Cre from the Foxp3 promoter) and Cis fl/fl mice. The T cell-specific deletion of Cis in Cis fl/fl CD4-Cre mice resulted in enhanced asthmatic responses, whereas the T reg cell-specific deletion of Cis in Cis fl/fl Foxp3-Cre mice did not (Fig. 4 and Supplementary Fig. 9 ). Cis fl/fl CD4-Cre mice had more total cells and eosinophils accumulation in the bronchoalveolar lavage fluid than did Cis fl/fl mice, whereas Cis fl/fl Foxp3-Cre mice and Cis fl/fl mice had similar numbers of all populations analyzed (Fig. 4a) . Lung infiltrates from Cis fl/fl CD4-Cre mice contained more CD4 + IL-4 + cells than did those of Cis fl/fl mice (Fig. 4b) . In addition, in response to restimulation ex vivo with ovalbumin, lung-associated lymph node cells and splenocytes from Cis fl/fl CD4-Cre mice secreted significantly higher concentrations of IL-4, IL-5 and IL-13 than did those from Cis fl/fl mice (Fig. 4c) . Total lung tissue from Cis fl/fl CD4-Cre mice also had more Il4, Il5, Il13 and Il9 mRNA than did that from Cis fl/fl mice (Fig. 4d) . Notably, we observed greater enhancement of T H 2 responses in Cis fl/fl CD4-Cre mice (Fig. 4c,d ) than in Cis −/− mice (Fig. 3c,d) . That might have partially resulted from the higher expression of IL-10 observed in T H 2 cells, which would further sustain the T H 2 polarization, as reported in an allergic skin model 35 . To obtain further evidence of the T cell-intrinsic role of CIS in allergic T cell development, we reconstituted mice with a congenital deficiency in mature B cells and T cells (deficient in recombinationactivating gene 1 (Rag1 −/− )) with T cell-depleted bone marrow from wild-type (CD45.1 + ) mice and Cis −/− (CD45.2 + ) mice (1:1 mixture) and induced asthma in the resulting mice. We found that Cis −/− cell populations had a higher frequency of IL-4 + and IL-13 + cells in lung infiltrates and draining lymph nodes than did their wild-type counterparts ( Supplementary Fig. 10a-c) . In addition, flow cytometrysorted Cis −/− (CD45.2 + ) CD4 + T cells had higher expression of Il4, Il5 and Il9 mRNA than did their wild-type (CD45.1 + ) counterparts (Supplementary Fig. 10d) . Therefore, CIS inhibited the induction of allergic lung disease by inhibiting the production of T H 2 and T H 9 cytokines in a T cell-intrinsic but T reg cell-extrinsic manner.
CIS inhibits T H 2 differentiation
Our in vivo data collectively supported the proposal of a role for CIS in the negative regulation of proallergic T H 2 and T H 9 responses. We next assessed the role of CIS in helper T cell differentiation in vitro. We sorted naive CD4 + T cells from Cis −/− mice and their wildtype littermates by flow cytometry and skewed the cells toward T H 1, T H 2, T H 17 or iT reg differentiation, then assessed the lineage-specific markers IFN-γ, IL-17, IL-4 and Foxp3, respectively, by intracellular staining. Under T H 1 conditions, the frequency of IFN-γ + cells among Cis −/− cells was similar to that among wild-type cells (Fig. 5a) , A r t i c l e s consistent with the normal activation of STAT1 in Cis −/− cells (Fig. 1d) . Under T H 17 conditions, the frequency of IL-17 + cells was also similar for both strains, but there were fewer Foxp3 + cells among Cis −/− cells than among their wild-type counterparts (Fig. 5a) ; this may have been due to enhanced STAT3 signaling. Under iT reg conditions, Cis −/− cell populations had a lower frequency of Foxp3 + cells than did their wild-type counterparts (Fig. 5a) . That difference was diminished when IL-4 was blocked (Fig. 5a) , which suggested that the enhanced T H 2 program mediated by CIS antagonized the iT reg program.
As expected, given the in vivo data, by intracellular staining or enhanced immunosorbent assay (ELISA), CIS deficiency led to enhanced T H 2 differentiation and expression of T H 2 cytokines in naive T cells activated under neutral, anti-IFN-γ or T H 2 conditions (Fig. 5b,c and Supplementary Fig. 11a ), which correlated with the enhanced activation of STAT5 and STAT6 observed in Cis −/− cells (Fig. 1d) . Furthermore, by quantitative RT-PCR, we found that when treated with anti-IFN-γ, Cis −/− cells had higher expression of not only mRNA encoding T H 2 cytokines (Il4, Il5, Il13 and Il10) but also mRNA encoding several T H 2-associated cell-surface receptors (Il4ra, Il17rb and Icos) and transcription factors (Gata3 and Irf4; Fig. 5d ). These results suggested that CIS inhibited the T H 2 differentiation program but not the T H 1 or T H 17 differentiation program and may have also regulated the iT reg program indirectly by restricting the T H 2 pathway.
CIS deficiency enhances T H 9 differentiation
In addition to IL-4, IL-5 and IL-13, IL-9 is also associated with allergic asthma [36] [37] [38] . TGF-β, together with IL-4, greatly enhances IL-9 expression, which results in T H 9 polarization 9-11 . Because we found higher expression of Il9 mRNA mice with germline or T cell-specific Cis deletion than in their CIS-sufficient counterparts (Figs. 3d and 4d) , we sought to determine whether CIS also inhibits T H 9 differentiation. We first assessed Il9 mRNA expression in wild-type and Cis −/− T cells differentiated from flow cytometry-sorted naive cells and activated for 4 d in the presence of anti-IFN-γ. We found that Il9 mRNA expression was much higher in the absence of CIS (Fig. 6a) . Next we polarized naive CD4 + T cells to differentiate into T H 9 cells and found that the resultant CIS-deficient (Cis −/− ) cell populations had many more IL-9 expressing cells than did their CIS-sufficient (wild-type (Fig. 6b) or Cis fl/fl (Supplementary Fig. 11b) ) counterparts. IL-9 production was also much greater in Cis −/− cells than in wild-type cells in the presence of anti-IFN-γ and T H 9 conditions (Fig. 6c) . Finally, to determine the cytokine-STAT signals that drive T H 9 differentiation, we activated naive CD4 + cells from wild-type and Cis −/− mice in the presence of anti-IFN-γ. We found more IL-4 + IL-9 + cells and IL-5 + cells among Cis −/− cells than among wild-type cells in this condition (Fig. 6d) . The addition of neutralizing antibody to IL-4 or IL-2 diminished the enhanced T H 9 and T H 2 responses of Cis −/− T cells (Fig. 6d) , which suggested signaling via both IL-4 and IL-2 was important in T H 9 differentiation as well as in T H 2 differentiation.
STAT5 and STAT6 regulate T H 9 differentiation
Signaling via IL-4 and IL-2 is known to activate STAT6 and STAT5, respectively. Our results indicated that CIS deficiency led to enhanced phosphorylation of STAT5 and STAT6 that was dependent on signaling via IL-4 and IL-2, respectively, as well as enhanced T H 9 and T H 2 responses in vitro and in vivo. Although both STAT5 and STAT6 are well known to regulate T H 2 differentiation, their roles in T H 9 development are unclear. We next examined the effect of STAT5 and STAT6 on T H 9 differentiation. To assess the role of STAT5, we studied the offspring of mice with one loxP-flanked Stat5a allele (Stat5a fl/+ or Stat5a fl/− ) crossed with Mx-Cre Ai3 mice (which express yellow fluorescent protein (YFP) after the induction of Cre expressed from the Mx1 promoter through the use of IFN-α). We obtained naive YFP + CD4 + T cells from those offspring and differentiated the cells toward the T H 9 lineage. We found that STAT5-deficient (Stat5a fl/− Mx-Cre) cell populations included considerably fewer IL-9 + cells than did their STAT5-sufficient (Stat5a fl/+ Mx-Cre) counterparts (Fig. 7a) . Conversely, forced expression of a constitutively active form of the STAT5A isoform of STAT5 (STAT5A1*6) 39 greatly enhanced T H 9 differentiation in the presence of anti-IFN-γ or under T H 9-differentiation conditions after 1 d of activation in the presence of anti-IFN-γ and infection with virus encoding STAT5A1*6 or control virus (Fig. 7b) .
To assess the role of STAT6, we differentiated naive CD4 + T cells from Stat6 −/− and BALB/c mice into T H 9 cells and found considerably fewer IL-9-expressing cells among Stat6 −/− cells than among wild-type cells, consistent with a published report 40 . Stat6 −/− cell populations also had a lower frequency of IL-4 + cells than did their wild-type (Fig. 7c) . In summary, our observations demonstrated that CIS negatively regulated the IL-4-STAT6 and IL-2-STAT5 pathways that were both important in T H 9 differentiation. Our results thus far showed that CIS inhibited T H 2 and T H 9 differentiation by antagonizing the activation of STAT5 and STAT6. STAT5 has been shown to bind to the Il4 locus-control region 41 , whereas STAT6 binds to the Il4 and Gata3 loci 42 . By comparison of mouse and human genomic DNA sequences with the ECR browser (of evolutionary conserved regions) 43 and rVISTA program 44 , we found potentially overlapping STAT5-and STAT6-binding sites (TGCCAG GAAATACCATTCCTCAGA and AGGAAATA, respectively) in the Il9 promoter. We sought to determine whether CIS controls the T H 2 and T H 9 programs by targeting the DNA-binding activity of STAT5 and STAT6. To address this question, we did chromatin immunoprecipitation (ChIP) with anti-STAT5, anti-STAT6 or a control antibody. We activated naive CD4 + T cells from wild-type and Cis −/− mice with plate-bound anti-CD3 and anti-CD28 in the presence (for STAT5 analysis) or absence (for STAT6 analysis) of IL-2. Through the use of anti-STAT5, we observed that the absence of CIS resulted in significantly more binding of STAT5 at the DNase I-hypersensitivity site HS2 of the Il4 locus and at the Il9 promoter (Fig. 7d) . Furthermore, as shown by the use of anti-STAT6, CIS deficiency led to significantly enhanced binding of STAT6 to the promoter and conserved noncoding sequence CNS1 of Gata3, the Il4 locus enhancer and the Il9 promoter (Fig. 7e) . Furthermore, in a luciferase reporter assay, STAT5 and STAT6 transactivated the transcription of a luciferase reporter driven by the Il9 promoter in the presence of the phorbol ester PMA (in the presence of IL-4, for STAT6 analysis; Fig. 7f,g ). These results therefore suggested that CIS attenuated T H 2 and T H 9 differentiation through inhibition of the phosphorylation of STAT5 and STAT6 and, in turn, their binding to genes encoding T H 2 and T H 9 signature cytokines.
DISCUSSION
Effector T cell differentiation is directed by the environmental cytokine milieu. STAT proteins are broadly engaged in cytokine signaling transduction and critically regulate the differentiation of helper T cells into the T H 1, T H 2 and T H 17 subsets. However, the involvement of STAT proteins in T H 9 cells is unclear. Because T H 9 differentiation requires IL-4, STAT6 is probably involved. STAT activity is negatively regulated by members of the SOCS family. SOCS1, SOCS3 and SOCS5 have been shown to regulate the differentiation of helper T cells through inhibition of STAT activation [12] [13] [14] . In this paper, we have reported an essential role for the SOCS family member CIS in the control of the proallergic differentiation of T H 2 and T H 9 cells and allergic disease. SOCS expression is induced by cytokine signals, mainly via activated STAT proteins. We tested a panel of cytokines that are important in the differentiation of helper T cells in the presence of signaling via the T cell antigen receptor and the coreceptor CD28. We found at the early phase of activation of helper T cell progenitors, IL-6 and IL-10 weakly induced CIS expression, whereas IL-4 strongly induced CIS expression. Consistent with that, in response to IL-4, IL-4Rα-deficient CD4 + T cells failed to upregulate Cis mRNA expression. However, STAT6-deficient CD4 + T cells had lower expression of Cis mRNA, approximately 50% that of wild-type cells. These data indicated in addition to STAT6, unknown factors mediated IL-4-induced CIS expression. Cis has been shown to be induced by STAT5 in liver cells 31 , erythroid progenitor cells 30 and human T lymphocytes 33 . Our results suggest that CIS may be regulated by distinct cytokines in a cell type-specific As IL-4 was the main inducer of CIS expression in the early phase of the differentiation of helper T cells, CIS may be involved in the IL-4-directed differentiation of helper T cells, such as T H 2 and T H 9 cells. Indeed, CIS deficiency led to spontaneously augmented T H 2 and T H 9 differentiation but not to the generation of T H 1 or T H 17 cells. As for iT reg cells, when differentiated with TGF-β and IL-2, CIS-deficient cell populations included fewer cells that were Foxp3 + , whereas after the addition of anti-IL-4, we did not observe this difference. Thus, in T reg cell differentiation, CIS seemed to act indirectly by enhancing the T H 2 response. Although T reg cells had high expression of CIS, genetic deletion of CIS in T reg cells did not lead to enhanced allergic diseases, which indicated a dispensable role for CIS in Foxp3 + nT reg or iT reg cells. It is also possible that other SOCS proteins, such as SOCS2, have redundant function in these cells.
Members of the SOCS family attenuate cytokine signaling by inhibiting the phosphorylation of STAT proteins. CIS has been shown to associate with the IL-2 receptor β-chain and to inhibit IL-2-dependent signaling by disruption of the Jak-STAT5 pathway 32, 33 . In this study, we found that CIS deficiency enhanced the phosphorylation of STAT3, STAT5 and STAT6 but not that of STAT1. The STAT5 signals were initiated by IL-2 because in the absence of exogenous IL-2, phosphorylation of STAT5 was delayed and there were no differences between wild-type and CIS-deficient cells in the phosphorylation of STAT5. With or without exogenous IL-2, the phosphorylation of STAT3 and STAT6 was not altered, which suggested that other cytokines were responsible for the activation of STAT3 and STAT6. When IL-4 was blocked with a neutralizing antibody, phosphorylated STAT6 signals disappeared, which indicated that a trace amount of IL-4 in the medium or from autocrine secretion was sufficient to induce the activation of STAT6. However, blockade of IL-6 and/or IL-21 or IL-4 did not change the activation of STAT3 in wild-type or CIS-deficient cells. At present, the cytokine that activates STAT3 is unclear. Together, the enhanced signaling via STAT5 and STAT6 may have accounted for the enhanced T H 2 response of CIS-deficient cells. Consistent with the lack of an effect of CIS deficiency on T H 1 differentiation, the activation of STAT1 was intact in CIS-deficient cells. CIS deficiency did not alter T H 17 differentiation; this may have been due to enhanced signaling via STAT5, a negative regulator of T H 17 differentiation 8 , counterbalanced by enhanced activation of STAT3.
T H 9 polarization is driven by IL-4 and TGF-β, which can activate the transcription factors PU.1 and IRF4 to establish the T H 9 program 45, 46 . In our study, CIS deficiency led to higher expression of Il9 mRNA and Irf4 mRNA but not of mRNA encoding PU.1 (Sfpi1), which suggested a more important role for IRF4 in T H 9 differentiation when CIS is absent. However, the STAT proteins that mediate T H 9 differentiation are not well understood. We found that in the presence of anti-IFN-γ, blockade of IL-4 or IL-2 resulted in a low frequency of CIS-deficient IL-9 + cells, whereas we observed no wild-type IL-9 + cells, which suggested involvement of signaling via IL-2-STAT5 and/or IL-4-STAT6 in T H 9 differentiation. To confirm that, we assessed the effect of STAT5 and STAT6 on T H 9 polarization. Conditional removal of STAT5A resulted in less T H 9 polarization, whereas forced expression of a constitutively activated form of STAT5A (STAT5A1*6) resulted in more T H 9 polarization. In addition to STAT5 deficiency, STAT6 deficiency profoundly impaired T H 9 skewing, consistent with a published report on STAT6-dependent regulation of T H 9 differentiation 40 . Moreover, we also demonstrated that in addition to binding to T H 2 signature genes (Gata3 and Il4), STAT5 and STAT6 bound to the Il9 promoter and transactivated its transcription. These data indicated essential roles for STAT5 and STAT6 in the generation of T H 9 cells.
In vivo, CIS-deficient mice were more susceptible to experimental allergic asthma, associated with enhanced T H 2 and T H 9 responses, in which more influx of eosinophils may manifest the acute allergic responses. In the asthma model, we also observed moderately more airway remodeling in CIS-deficient mice (data not shown). With aging, CIS-deficient mice spontaneously developed allergic pulmonary disease with alveolar epithelial cell and airway muscle cell hyperplasia and more eosinophils in lungs. This may have been due to chronically higher expression of the T H 2 cytokine IL-13 (refs. [47] [48] [49] and the T H 9 cytokine IL-9 (refs. 36-38,49). As both T H 2 differentiation and T H 9 differentiation require IL-4, the higher IL-4 expression in CIS-deficient mice may have further augmented the T H 2 and T H 9 responses. Moreover, IL-9 also promotes IL-13 expression in airway epithelial cells 50 , which further amplifies the effect of IL-13. Notably, we did not observe the spontaneous airway remodeling in 1-yearold Cis fl/fl CD4-Cre mice (data not shown), which suggested that the enhanced T H 2 and T H 9 responses were not the only pathogenic factors and that defective CIS signaling in other cells (cells of the innate immune system and/or airway structural cells, for example) may have had a role in this. Notably, innate sources of IL-9 and IL-13 have been shown to be important regulators of lung inflammation, especially in acute allergic responses 51, 52 . The role of CIS in cell types other than T H 2 and T H 9 cells needs further investigation.
In summary, we found that CIS, induced by IL-4 (and also IL-2 at the late phase), attenuated signaling via IL-2-STAT5 and IL-4-STAT6 during T H 2 and T H 9 differentiation by diminishing the binding of STAT5 and STAT6 to T H 2 and T H 9 signature genes. Therefore, our data suggest negative feedback by the CIS-STAT5 and CIS-STAT6 pathways in T H 2 and T H 9 differentiation. Our results may help to elucidate the pathogenesis of human allergic diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
